MentionFox
Home › Layoffs › Zentalis Pharmaceuticals, Inc.
SEC filings · Form 8-K, Item 2.05

Zentalis Pharmaceuticals, Inc. layoffs and restructuring

Before you join, sell to or invest in Zentalis Pharmaceuticals, Inc.

MentionFox check on Zentalis Pharmaceuticals, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/zentalis-pharmaceuticals

  • Note: Layoff plan disclosed Jan 2025 (filing)

New since last check: Layoff plan disclosed Jan 2025 (filing, first seen 14 November 2026).

Check Zentalis Pharmaceuticals, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Zentalis Pharmaceuticals, Inc.?

Every exit or restructuring plan Zentalis Pharmaceuticals, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

Zentalis Pharmaceuticals, Inc.'s latest layoff filing, on January 28, 2025, states charges of approximately $7.0-8.0 million. As of November 14, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, January 28, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Matrix Capital Management Company, LP also filed stake reports on 2 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Zentalis Pharmaceuticals, Inc.

Watch Zentalis Pharmaceuticals, Inc.: email me the next time it files something

Free to see. No signup.

People from Zentalis Pharmaceuticals, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Zentalis Pharmaceuticals, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2025-01-28

Zentalis Pharmaceuticals, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Zentalis Pharmaceuticals have layoffs in 2025? What its filings say

Zentalis Pharmaceuticals, Inc. (CIK 1725160) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-01-28

Expected charges

The Company expects to incur one-time costs of approximately $7.0-8.0 million in the first quarter of 2025 in connection with the workforce reduction.

Also on the record for Zentalis Pharmaceuticals, Inc.

DateRecordFigureOur pageSource
October 27, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.4.1% of the class5%+ stakesSource
August 19, 2026Stake report, Schedule 13G/A, by Walters William T18.8% of the class5%+ stakesSource
August 13, 2026Stake report, Schedule 13G/A, by Barclays PLC3.17% of the class5%+ stakesSource
July 30, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.2% of the class5%+ stakesSource
May 27, 2026Leadership change: Shannon Campbell appointed, Director—Leadership changesSource
March 3, 2026Stake report, Schedule 13G, by Squadron Master Fund LP5.1% of the class5%+ stakesSource
January 5, 2026Stake report, Schedule 13G/A, by Walters William T19.7% of the class5%+ stakesSource
January 2, 2026Stake report, Schedule 13D/A, by Matrix Capital Management Company, LP—5%+ stakesSource
December 30, 2025Stake report, Schedule 13G, by Andrew J. Schwab6.4% of the class5%+ stakesSource
December 15, 2025Stake report, Schedule 13D/A, by Matrix Capital Management Company, LP9.98% of the class5%+ stakesSource
November 12, 2025Stake report, Schedule 13G, by Barclays PLC5.32% of the class5%+ stakesSource
October 14, 2025Stake report, Schedule 13G/A, by Millennium Management LLC1.3% of the class5%+ stakesSource

Keep reading

More on Zentalis Pharmaceuticals, Inc. and the records around it.

Zentalis Pharmaceuticals, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Zentalis Pharmaceuticals, Inc.?

Want the whole picture on Zentalis Pharmaceuticals, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Zentalis Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Zentalis Pharmaceuticals, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 13 records.

Tools for this story

Each opens in a new tab, filled in for Zentalis Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/zentalis-pharmaceuticals
Last updated 2026-11-14
Zentalis Pharmaceuticals, Inc. layoffs and restructuring: 1 SEC filing (2025-01-28). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/zentalis-pharmaceuticals